Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Clinical Oncology
|
September 25, 2014
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases
Naoki Izawa, Yusuke Onozawa, Tomomi Hikosaka, et al.
Molecular and Clinical Oncology
|
December 2, 2015
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin
Yoshiki Horie, Kentaro Yamazaki, Taro Funakoshi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2022
A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701
Kazuma Kobayshi, Koichi Suyama, Hiroo Katsuya, et al.
Clinical Colorectal Cancer
|
March 29, 2024
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, et al.
Journal of Gastroenterology
|
May 23, 2026
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens
Kumiko Umemoto, Kazunari Nakahara, Nobuyuki Ohike, et al.
BMC Cancer
|
December 16, 2022
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, et al.
World Journal of Gastroenterology
|
November 1, 2012
Gastrointestinal stromal tumor presenting with prominent calcification
Naoki Izawa, Takeshi Sawada, Ryuichi Abiko, et al.
Nutrition and Cancer
|
March 23, 2021
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment
Takuro Mizukami, Koki Hamaji, Risa Onuki, et al.
BMJ Open
|
December 18, 2020
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy
Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, et al.
Targeted Oncology
|
September 22, 2020
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
Naoki Izawa, Kohei Shitara, Kimio Yonesaka, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Clinical Oncology
|
September 25, 2014
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases
Naoki Izawa, Yusuke Onozawa, Tomomi Hikosaka, et al.
Molecular and Clinical Oncology
|
December 2, 2015
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin
Yoshiki Horie, Kentaro Yamazaki, Taro Funakoshi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2022
A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701
Kazuma Kobayshi, Koichi Suyama, Hiroo Katsuya, et al.
Clinical Colorectal Cancer
|
March 29, 2024
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, et al.
Journal of Gastroenterology
|
May 23, 2026
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens
Kumiko Umemoto, Kazunari Nakahara, Nobuyuki Ohike, et al.
BMC Cancer
|
December 16, 2022
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, et al.
World Journal of Gastroenterology
|
November 1, 2012
Gastrointestinal stromal tumor presenting with prominent calcification
Naoki Izawa, Takeshi Sawada, Ryuichi Abiko, et al.
Nutrition and Cancer
|
March 23, 2021
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment
Takuro Mizukami, Koki Hamaji, Risa Onuki, et al.
BMJ Open
|
December 18, 2020
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy
Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, et al.
Targeted Oncology
|
September 22, 2020
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
Naoki Izawa, Kohei Shitara, Kimio Yonesaka, et al.
Page
of 7